{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-024942","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.914662+00:00","generated_at":"2026-06-02T08:26:30.683194+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nu Skin Q1 revenue $417.3M, down 13%; EPS $(0.01) GAAP; customer base shrinks 19%","bullets":["Revenue $417.3M, down 13.3% YoY; foreign currency hit of $18.2M; Rhyz revenue up 57.5% to $62.5M.","GAAP EPS $(0.01); adjusted EPS $0.09 ex-restructuring vs $0.37 prior year; gross margin 70.5%.","Customers 875,261 (-19%); paid affiliates 154,171 (-30%); sales leaders 38,609 (-12%).","Q2 2024 guidance: revenue $420-455M, EPS $0.01-0.10 GAAP; 2024 full-year revenue $1.73-1.87B.","CEO cites macro headwinds; cost management supported earnings; India opening expected next year."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-024942","json":"https://secwatch.observer/filing/0001140361-24-024942.json","markdown":"https://secwatch.observer/filing/0001140361-24-024942.md","text":"https://secwatch.observer/filing/0001140361-24-024942.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036124024942/0001140361-24-024942-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036124024942/ef20028686_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T08:26:30.683194+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b0c6db0be91be5cc15ca574e8ec351a6c8eedc0d","claim":"NU SKIN ENTERPRISES, INC. reported the three-month period ended March 31, 2024 results: revenue $417.3 million, EPS $(0.01) or $0.09 excluding restructuring charges. Guidance reaffirmed.","evidence_excerpt":"Nu Skin Enterprises Reports First Quarter Results PROVO, Utah — May 8, 2024 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter results in line with guidance. Executive Summary Q1 2024 vs. Prior-year Quarter Revenue $417.3 million; (13.3)% • (3.8)% FX impact or $(18.2) million • Rhyz revenue $62.5 million; 57.5% Earnings Per Share (EPS) $(0.01) or $0.09 excluding restructuring charges compared to $0.23 or $0.37 excluding restructuring charges Customers 875,261; (19)% Paid Affiliates 154,171; (30)% or (14)% excluding an adjustment to eligibility requirements Sales Leaders 38,609; (12)%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1021561/000114036124024942/0001140361-24-024942-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three-month period ended March 31, 2024"},{"label":"Revenue","value":"$417.3 million"},{"label":"EPS","value":"$(0.01) or $0.09 excluding restructuring charges"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}